Cargando…

Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study

BACKGROUND: Prevalence of both degenerative severe aortic stenosis (AS) and transthyretin cardiac amyloidosis (ATTR-CA) increases with age. Dual disease (AS+myocardial ATTR-CA) occurs in significant proportion of patients undergoing surgical aortic valve replacement (SAVR). OBJECTIVES: This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Singal, Aayush Kumar, Bansal, Raghav, Singh, Avinainder, Dorbala, Sharmila, Sharma, Gautam, Gupta, Kartik, Saxena, Anita, Bhargava, Balram, Karthikeyan, Ganesan, Ramakrishnan, Sivasubramanian, Bisoi, Akshay Kumar, Hote, Milind Padmakar, Rajashekar, Palleti, Chowdhury, Ujjwal Kumar, Devagourou, Velayoudam, Patel, Chetan, Ray, Ruma, Arawa, Sudheer Kumar, Mishra, Sundeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551518/
https://www.ncbi.nlm.nih.gov/pubmed/34746852
http://dx.doi.org/10.1016/j.jaccao.2021.08.008
_version_ 1784591176091828224
author Singal, Aayush Kumar
Bansal, Raghav
Singh, Avinainder
Dorbala, Sharmila
Sharma, Gautam
Gupta, Kartik
Saxena, Anita
Bhargava, Balram
Karthikeyan, Ganesan
Ramakrishnan, Sivasubramanian
Bisoi, Akshay Kumar
Hote, Milind Padmakar
Rajashekar, Palleti
Chowdhury, Ujjwal Kumar
Devagourou, Velayoudam
Patel, Chetan
Ray, Ruma
Arawa, Sudheer Kumar
Mishra, Sundeep
author_facet Singal, Aayush Kumar
Bansal, Raghav
Singh, Avinainder
Dorbala, Sharmila
Sharma, Gautam
Gupta, Kartik
Saxena, Anita
Bhargava, Balram
Karthikeyan, Ganesan
Ramakrishnan, Sivasubramanian
Bisoi, Akshay Kumar
Hote, Milind Padmakar
Rajashekar, Palleti
Chowdhury, Ujjwal Kumar
Devagourou, Velayoudam
Patel, Chetan
Ray, Ruma
Arawa, Sudheer Kumar
Mishra, Sundeep
author_sort Singal, Aayush Kumar
collection PubMed
description BACKGROUND: Prevalence of both degenerative severe aortic stenosis (AS) and transthyretin cardiac amyloidosis (ATTR-CA) increases with age. Dual disease (AS+myocardial ATTR-CA) occurs in significant proportion of patients undergoing surgical aortic valve replacement (SAVR). OBJECTIVES: This study aimed to determine the prevalence of ATTR-CA in severe AS in the Indian population, identify noninvasive predictors of its diagnosis, and understand its impact on prognosis. METHODS: Symptomatic severe AS patients aged ≥65 years undergoing SAVR were enrolled. ATTR-CA diagnosis was based on preoperative 99m-technetium pyrophosphate (PYP) scan and intraoperatively obtained basal interventricular septum biopsy for myocardial ATTR-CA, and excised native aortic valve for isolated valvular ATTR-CA. Primary amyloidosis was excluded by serum/urine protein electrophoresis with serum immunofixation. RESULTS: SAVR was performed in 46 AS patients (age 70 ± 5 years, 70% men). PYP scan was performed for 32 patients, with significant PYP uptake in 3 (n = 3 of 32, 9.4%), suggestive of myocardial ATTR-CA. On histopathological examination, none of the interventricular septum biopsy specimens had amyloid deposits, whereas 33 (71.7%) native aortic valves showed amyloid deposits, of which 19 (57.6%) had transthyretin deposition suggestive of isolated valvular amyloidosis. Noninvasive markers of dual disease included low myocardial contraction fraction (median [interquartile range], 28.8% [23.8% to 39.1%] vs 15.3% [9.3% to 16.1%]; P = 0.006), deceleration time (215 [144 to 236] ms vs 88 [60 to 106] ms; P = 0.009) and global longitudinal strain (-18.7% [-21.1% to -16.9%] vs -14.2% [-17.0% to -9.7%]; P = 0.030). At 1-year follow-up, 2 patients died (4.3%); 1 each in myocardial ATTR-CA negative and positive groups (3.4% vs 33.3%; P = 0.477). CONCLUSIONS: Dual disease is not uncommon in India. Isolated valvular amyloidosis in severe AS is much more common.
format Online
Article
Text
id pubmed-8551518
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85515182021-11-04 Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study Singal, Aayush Kumar Bansal, Raghav Singh, Avinainder Dorbala, Sharmila Sharma, Gautam Gupta, Kartik Saxena, Anita Bhargava, Balram Karthikeyan, Ganesan Ramakrishnan, Sivasubramanian Bisoi, Akshay Kumar Hote, Milind Padmakar Rajashekar, Palleti Chowdhury, Ujjwal Kumar Devagourou, Velayoudam Patel, Chetan Ray, Ruma Arawa, Sudheer Kumar Mishra, Sundeep JACC CardioOncol Original Research BACKGROUND: Prevalence of both degenerative severe aortic stenosis (AS) and transthyretin cardiac amyloidosis (ATTR-CA) increases with age. Dual disease (AS+myocardial ATTR-CA) occurs in significant proportion of patients undergoing surgical aortic valve replacement (SAVR). OBJECTIVES: This study aimed to determine the prevalence of ATTR-CA in severe AS in the Indian population, identify noninvasive predictors of its diagnosis, and understand its impact on prognosis. METHODS: Symptomatic severe AS patients aged ≥65 years undergoing SAVR were enrolled. ATTR-CA diagnosis was based on preoperative 99m-technetium pyrophosphate (PYP) scan and intraoperatively obtained basal interventricular septum biopsy for myocardial ATTR-CA, and excised native aortic valve for isolated valvular ATTR-CA. Primary amyloidosis was excluded by serum/urine protein electrophoresis with serum immunofixation. RESULTS: SAVR was performed in 46 AS patients (age 70 ± 5 years, 70% men). PYP scan was performed for 32 patients, with significant PYP uptake in 3 (n = 3 of 32, 9.4%), suggestive of myocardial ATTR-CA. On histopathological examination, none of the interventricular septum biopsy specimens had amyloid deposits, whereas 33 (71.7%) native aortic valves showed amyloid deposits, of which 19 (57.6%) had transthyretin deposition suggestive of isolated valvular amyloidosis. Noninvasive markers of dual disease included low myocardial contraction fraction (median [interquartile range], 28.8% [23.8% to 39.1%] vs 15.3% [9.3% to 16.1%]; P = 0.006), deceleration time (215 [144 to 236] ms vs 88 [60 to 106] ms; P = 0.009) and global longitudinal strain (-18.7% [-21.1% to -16.9%] vs -14.2% [-17.0% to -9.7%]; P = 0.030). At 1-year follow-up, 2 patients died (4.3%); 1 each in myocardial ATTR-CA negative and positive groups (3.4% vs 33.3%; P = 0.477). CONCLUSIONS: Dual disease is not uncommon in India. Isolated valvular amyloidosis in severe AS is much more common. Elsevier 2021-10-19 /pmc/articles/PMC8551518/ /pubmed/34746852 http://dx.doi.org/10.1016/j.jaccao.2021.08.008 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Singal, Aayush Kumar
Bansal, Raghav
Singh, Avinainder
Dorbala, Sharmila
Sharma, Gautam
Gupta, Kartik
Saxena, Anita
Bhargava, Balram
Karthikeyan, Ganesan
Ramakrishnan, Sivasubramanian
Bisoi, Akshay Kumar
Hote, Milind Padmakar
Rajashekar, Palleti
Chowdhury, Ujjwal Kumar
Devagourou, Velayoudam
Patel, Chetan
Ray, Ruma
Arawa, Sudheer Kumar
Mishra, Sundeep
Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study
title Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study
title_full Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study
title_fullStr Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study
title_full_unstemmed Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study
title_short Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population: A Pilot Study
title_sort concomitant transthyretin amyloidosis and severe aortic stenosis in elderly indian population: a pilot study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551518/
https://www.ncbi.nlm.nih.gov/pubmed/34746852
http://dx.doi.org/10.1016/j.jaccao.2021.08.008
work_keys_str_mv AT singalaayushkumar concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT bansalraghav concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT singhavinainder concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT dorbalasharmila concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT sharmagautam concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT guptakartik concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT saxenaanita concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT bhargavabalram concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT karthikeyanganesan concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT ramakrishnansivasubramanian concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT bisoiakshaykumar concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT hotemilindpadmakar concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT rajashekarpalleti concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT chowdhuryujjwalkumar concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT devagourouvelayoudam concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT patelchetan concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT rayruma concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT arawasudheerkumar concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy
AT mishrasundeep concomitanttransthyretinamyloidosisandsevereaorticstenosisinelderlyindianpopulationapilotstudy